Lung, Spleen, and Kidney Are the Major Places for Inducible Nitric Oxide Synthase Expression in Endotoxic Shock: Role of P38 Mitogen-Activated Protein Kinase in Signal Transduction of Inducible Nitric Oxide Synthase Expression
- 1 March 2004
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Shock
- Vol. 21 (3), 281-287
- https://doi.org/10.1097/01.shk.0000113314.37747.55
Abstract
Bacterial lipopolysaccharide (LPS) is known to induce endotoxic shock with inducible nitric oxide (NO) synthase (iNOS) expression and NO production. However, the major place for NO production in shock remains unclear. Although there is some literature about p38 mitogen-activated protein kinase (MAPK) in regulating LPS-induced iNOS expression, the results are contradictory. To interpret the precise cell mechanism and the role of p38 MAPK in the expression of iNOS during endotoxic shock, we carried out the following investigations. A severe endotoxic shock model was reproduced in mice 6 h after LPS injection. The plasma NO level was increased in a dose- and time-dependent manner after LPS stimulation and was suppressed by administration of SB203580 [4-(4-fluorophenyl)-2-4-methylsulfonylphenyl-5-(4-pyridyl) imidazole], a highly specific inhibitor of p38 MAPK. The iNOS expression was increased in many organs, including heart, liver, spleen, lung, gut, and kidney in endotoxic shock. Among them, the highest expression of iNOS mRNA and protein was in the lung, moderate expression was in the spleen and kidney, and the lowest expression was in the heart, gut, and liver. The level of expression in lung was 5.5 times that of iNOS mRNA and was 3.1 times that of iNOS protein than in heart, and 1.6 and 1.8 times that of iNOS mRNA and 1.7 and 1.4 times that of iNOS protein than in spleen and kidney, respectively. The p38 MAPK activity increased after LPS injection, and SB203580 markedly reduced LPS-induced expressions of iNOS protein and mRNA in the lung. The results indicates that lung, spleen, and kidney are the major places for iNOS expression in endotoxic shock and are important therapeutic target organs for attenuating NO production in shock treatment.Keywords
This publication has 25 references indexed in Scilit:
- S-nitroso-N-acetylpenicillamine (SNAP) During Hemorrhagic Shock Improves Mortality as a Result of Recovery From Vascular HyporeactivityAnesthesia & Analgesia, 2000
- Contribution of Macrophages to Pulmonary Nitric Oxide Production in Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Expression of Inducible Nitric Oxide Synthase by Macrophages in Rat LungAmerican Journal of Respiratory and Critical Care Medicine, 1997
- LOW-LEVEL EXPRESSION AND LIMITED ROLE FOR THE INDUCIBLE ISOFORM OF NITRIC OXIDE SYNTHASE IN THE VASCULAR HYPOREACTIVITY AND MORTALITY ASSOCIATED WITH CECAL LIGATION AND PUNCTURE IN THE RATShock, 1996
- Nitric Oxide Induces Upregulation of Fas and Apoptosis in Vascular Smooth MuscleHypertension, 1996
- The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthaseBritish Journal of Pharmacology, 1995
- Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shockBritish Journal of Pharmacology, 1995
- Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase.Proceedings of the National Academy of Sciences, 1994
- Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells.Proceedings of the National Academy of Sciences, 1994
- Nitric Oxide Synthase in Human and Rat Lung: Immunocytochemical and Histochemical LocalizationAmerican Journal of Respiratory Cell and Molecular Biology, 1993